Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenters Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
October 2017—North West London Pathology, hosted by Imperial College Healthcare NHS Trust, and Abbott have signed a $252 million managed equipment services contract for the supply of all analytical equipment and consumables, including Abbott’s Alinity ci and Alinity h series diagnostics instruments as well as its professional services and informatics solutions known as AlinIQ.
October 2017—sCMOS, with Sony’s Pregius CMOS sensor. The RT sCMOS is optimal for fluorescence microscopy, fluorescent in situ hybridization, green fluorescent protein (GFP) imaging, immunofluorescence, and 3-D deconvolution applications. Features include deep cooling, which allows dim images to be seen without becoming obscured by dark current; a global shutter, which ensures undistorted images of moving specimens; and 5 megapixel live and captured image resolution. The sCMOS is nine times more sensitive than the previous RT camera.
October 2017—Grifols and Beckman Coulter have entered into an exclusive, long-term agreement for the global distribution of Grifols’ hemostasis instruments, reagents, and consumables. The companies anticipate first commercializing systems under this agreement in Europe in early 2018.
October 2017—Ortho Clinical Diagnostics announced that its Vitros Immunodiagnostic Products Insulin Reagent and Calibrators have received FDA clearance and the CE mark. The assay is expected to be commercially available for use on all of the company’s Vitros immunodiagnostic and integrated systems in Europe, in other countries accepting the CE mark, and in the U.S. during the third quarter of this year.
October 2017—The Clinical and Laboratory Standards Institute has published a microbiology guideline, “M58: Methods for the Identification of Cultured Microorganisms Using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry, 1st ed.”
October 2017—Baebies, a Durham, NC–based company focused on advancing newborn screening and pediatric testing, has signed a bilateral distribution agreement with Trivitron’s Labsystems Diagnostics to deliver newborn screening solutions to several markets worldwide. Baebies will distribute Labsystems’ newborn screening products NeoMass AAAC and NS 2400 in the United States after obtaining regulatory clearance.
October 2017—Metabolon has acquired Metabolomic Discoveries, a metabolomics services and diagnostics company based near Berlin, Germany.
October 2017—Thermo Scientific Samco Clicktainer leakproof vials have been developed to provide sample protection and user safety by enabling correct cap application. The vials are designed for the secure collection and handling of fluid, solid, and powder samples, including urine, sputum, and stool specimens; the lid-lock design makes them ideal for the secure transport of clinical, research, and forensic samples.
October 2017—PerkinElmer is collaborating with In-Depth Genomics to support IDG’s whole genome sequencing diagnostic program, which will bring genetic diagnosis to patients who have a wide range of neurological conditions, including orphan disorders, and aims to provide improved diagnoses and treatments.
October 2017—Ambry Genetics and NorthShore University HealthSystem’s Center for Personalized Medicine (Evanston, Ill.) will partner to offer genetic testing and research to advance precision medicine in preventive care.
